TY - JOUR
T1 - Study protocol
T2 - analysis of regional lung health policies and stakeholders in Africa
AU - On behalf of The IMPALA Consortium
AU - Jensen, Claire
AU - Heneine, Emma
AU - Mungai, Brenda
AU - Murunga, Violet
AU - Hara, Hleziwe
AU - Oronje, Rose
AU - Obasi, Angela
AU - Squire, Bertie
AU - Zulu, Eliya
AU - Squire, Bertie
AU - Mortimer, Kevin
AU - Obasi, Angela
AU - Tolhurst, Rachel
AU - Taegtmeyer, Miriam
AU - Khan, Jahangir
AU - Niessen, Louis
AU - Bates, Imelda
AU - Mbatchou, Bertrand
AU - Binegdie, Amsalu
AU - Addo-Yobo, Emmanuel
AU - Zulu, Eliya
AU - Meme, Hellen
AU - Banda, Hastings
AU - Rylance, Jamie
AU - Falade, Adegoke
AU - Zar, Heather
AU - Zurba, Lindsay
AU - Allwood, Brian
AU - Lesosky, Maia
AU - El Sony, Asma
AU - Ntinginya, Nyanda Elias
AU - Mutayoba, Beatrice
AU - Worodria, William
N1 - Funding Information:
The IMPALA Consortium is made up of the following authors: Bertie Squire, Kevin Mortimer, Angela Obasi, Rachel Tolhurst, Miriam Taegtmeyer, Jahangir Khan, Louis Niessen, Imelda Bates, Bertrand Mbatchou, Amsalu Binegdie, Emmanuel Addo-Yobo, Eliya Zulu, Hellen Meme, Hastings Banda, Jamie Rylance, Adegoke Falade, Heather Zar, Lindsay Zurba, Brian Allwood, Maia Lesosky, Asma El Sony, Nyanda Elias Ntinginya, Beatrice Mutayoba and William Worodria.
Funding Information:
This research was funded by the National Institute for Health Research (NIHR) (project reference 16/136/35) using United Kingdom aid from the United Kingdom Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the United Kingdom Department of Health and Social Care.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12
Y1 - 2020/12
N2 - Background: Lung health is a critical area for research in sub-Saharan Africa. The International Multidisciplinary Programme to Address Lung Health and TB in Africa (IMPALA) is a collaborative programme that seeks to fill evidence gaps to address high-burden lung health issues in Africa. In order to generate demand for and facilitate use of IMPALA research by policy-makers and other decision-makers at the regional level, an analysis of regional lung health policies and stakeholders will be undertaken to inform a programmatic strategy for policy engagement. Methods and analysis: This analysis will be conducted in three phases. The first phase will be a rapid desk review of regional lung health policies and stakeholders that seeks to understand the regional lung health policy landscape, which issues are prioritised in existing regional policy, key regional actors, and opportunities for engagement with key stakeholders. The second phase will be a rapid desk review of the scientific literature, expanding on the work in the first phase by looking at the external factors that influence regional lung health policy, the ways in which regional bodies influence policy at the national level, investments in lung health, structures for discussion and advocacy, and the role of evidence at the regional level. The third phase will involve a survey of IMPALA partners and researchers as well as interviews with key regional stakeholders to further shed light on regional policies, including policy priorities and gaps, policy implementation status and challenges, stakeholders, and platforms for engagement and promoting uptake of evidence. Discussion: Health policy analysis provides insights into power dynamics and the political nature of the prioritisation of health issues, which are often overlooked. In order to ensure the uptake of new knowledge and evidence generated by IMPALA, it is important to consider these complex factors.
AB - Background: Lung health is a critical area for research in sub-Saharan Africa. The International Multidisciplinary Programme to Address Lung Health and TB in Africa (IMPALA) is a collaborative programme that seeks to fill evidence gaps to address high-burden lung health issues in Africa. In order to generate demand for and facilitate use of IMPALA research by policy-makers and other decision-makers at the regional level, an analysis of regional lung health policies and stakeholders will be undertaken to inform a programmatic strategy for policy engagement. Methods and analysis: This analysis will be conducted in three phases. The first phase will be a rapid desk review of regional lung health policies and stakeholders that seeks to understand the regional lung health policy landscape, which issues are prioritised in existing regional policy, key regional actors, and opportunities for engagement with key stakeholders. The second phase will be a rapid desk review of the scientific literature, expanding on the work in the first phase by looking at the external factors that influence regional lung health policy, the ways in which regional bodies influence policy at the national level, investments in lung health, structures for discussion and advocacy, and the role of evidence at the regional level. The third phase will involve a survey of IMPALA partners and researchers as well as interviews with key regional stakeholders to further shed light on regional policies, including policy priorities and gaps, policy implementation status and challenges, stakeholders, and platforms for engagement and promoting uptake of evidence. Discussion: Health policy analysis provides insights into power dynamics and the political nature of the prioritisation of health issues, which are often overlooked. In order to ensure the uptake of new knowledge and evidence generated by IMPALA, it is important to consider these complex factors.
KW - Africa lung health
KW - Lung health policy
KW - non-communicable diseases
KW - policy stakeholder analysis
KW - tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85097393116&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097393116&partnerID=8YFLogxK
U2 - 10.1186/s12961-020-00618-5
DO - 10.1186/s12961-020-00618-5
M3 - Article
C2 - 33298052
AN - SCOPUS:85097393116
SN - 1478-4505
VL - 18
JO - Health Research Policy and Systems
JF - Health Research Policy and Systems
IS - 1
M1 - 135
ER -